SERA News and Press, Sera Prognostics Inc. From 10/25/23

Sera Prognostics Announces Conference Call and Webcast of Third Quarter Fiscal Year 2023 Financial Results on November 8, 2023 PR Newswire SALT LAKE CITY , Oct. 25, 2023 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), f...

SERA PROGNOSTICS TO PRESENT AT CANTOR FITZGERALD GLOBAL HEALTHCARE CONFERENCE 2023 PR Newswire SALT LAKE CITY , Sept. 21, 2023 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company ® (Nasdaq: SERA), focused on improving maternal and neonatal h...

2023-08-11 15:25:24 ET Sera Prognostics, Inc. (SERA) Q2 2023 Earnings Conference Call August 9, 2023 5:00 PM ET Company Participants Peter DeNardo – Investor Relations-CapComm Partners Zhenya Lindgardt – Interim President and Chief Executive Officer ...

2023-08-09 16:28:53 ET Sera Prognostics press release ( NASDAQ: SERA ): Q2 GAAP EPS of -$0.34 in-line. Revenue of $0.12M (+71.4% Y/Y) beats by $0.03M . For further details see: Sera Prognostics GAAP EPS of -$0.34 in-line, revenue of $0.12M beats by $0.03M

SERA PROGNOSTICS REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS PR Newswire SALT LAKE CITY , Aug. 9, 2023 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing inno...

Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2023 Financial Results on August 9, 2023 PR Newswire SALT LAKE CITY , July 31, 2023 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company ® (NASDAQ: SERA)...

2023-06-08 18:58:38 ET Summary Sera Prognostics is a promising company with a mission to improve pregnancy outcomes through its blood test product, PreTRM, which identifies biomarkers linked to premature birth. Premature birth is a significant issue, with 1 in 10 babies born prema...

Sera Prognostics Announces Commercial Changes and Actions to Optimize Business for Market Success Toward Accelerating Test Adoption and Revenue PR Newswire Aligning Management Team given New Refined Commercial Focus on Institutions Starting with Recent Appointment of Board Mem...

2023-05-15 17:53:03 ET Sera Prognostics ( NASDAQ: SERA ) announced on Monday the retirement of its president and CEO, Gregory Critchfield. Critchfield plans to step down from his executive role effective June 8. Zhenya Lindgardt will succeed Critchfield as interi...

Sera Prognostics Announces Retirement of President and CEO Dr. Greg Critchfield and Appointment of Board Member Zhenya Lindgardt as Interim CEO PR Newswire SALT LAKE CITY , May 15, 2023 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company ® (NASD...